Login / Signup

Vasoactive Intestinal Peptide Receptor, CRTH2, Antagonist Treatment Improves Eosinophil and Mast Cell-Mediated Esophageal Remodeling and Motility Dysfunction in Eosinophilic Esophagitis.

Chandra Sekhar YadavalliSathisha Upparahalli VenkateshaiahAlok K VermaChandrasekhar KatheraPearce S DuncanMichael VaeziRichard J PaulAnil Mishra
Published in: Cells (2024)
CRTH2 antagonist treatment is a novel therapeutic strategy for inflammatory cell-induced esophageal motility dysfunction in IL-13-induced chronic experimental EoE.
Keyphrases
  • oxidative stress
  • diabetic rats
  • high glucose
  • single cell
  • biofilm formation
  • stem cells
  • combination therapy
  • mesenchymal stem cells